CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Biolargo, Inc.  (BLGO)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Equipment & Supplies
 
 

BLGO's Revenue Year on Year Growth by Quarter and Year

Biolargo,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
BLGO Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 0.07 - 0.06
III Quarter September - 0.16 0.04 0.02
II Quarter June 0.10 0.04 0.04 0.02
I Quarter March 0.05 0.01 0.03 0.01
FY   0.15 0.28 0.11 0.11

Financial Statements
Biolargo,'s second quarter 2017 Revenue $ 0.10 millions BLGO's Income Statement
Biolargo,'s second quarter 2016 Revenue $ 0.04 millions Quarterly BLGO's Income Statement
BLGO's Growth by Division See BLGO's Growth by Segment

BLGO Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - - - -
III Quarter September - 300 % 100 % -
II Quarter June 149.95 % 0 % 100 % -
I Quarter March 400 % -66.67 % 200 % -
FY   - 154.55 % 0 % -



BLGO Revenue Growth Comment
Biolargo, Inc. achieved in the second quarter, above Company average Revenue surge of 149.95% year on year, to $ 0.10 millions.

Looking into second quarter results within Medical Equipment & Supplies industry 3 other companies have achieved higher Revenue growth. While Biolargo, Inc.' s Revenue doubling of 149.95% ranks overall at the positon no. 144 in the second quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #4
Healthcare Sector #41
Overall #144
Revenue Y/Y Growth Statistics
High Average Low
274.57 % 105.65 % -100 %
(Sep 30 2016)   (Dec 31 2015)

You need to upgrade your Flash Player

Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BLGO's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for BLGO's Competitors
Revenue Growth for Biolargo,'s Suppliers
Revenue Growth for BLGO's Customers

You may also want to know
BLGO's Annual Growth Rates BLGO's Profitability Ratios BLGO's Asset Turnover Ratio BLGO's Dividend Growth
BLGO's Roe BLGO's Valuation Ratios BLGO's Financial Strength Ratios BLGO's Dividend Payout Ratio
BLGO's Roa BLGO's Inventory Turnover Ratio BLGO's Growth Rates BLGO's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Jun 30 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2017
Zogenix, Inc.  241.24 %$ 241.236 millions
Steadymed Ltd.  239.36 %$ 239.362 millions
Arbutus Biopharma Corp  236.25 %$ 236.246 millions
Apollo Medical Holdings, Inc.  236.05 %$ 236.054 millions
Neos Therapeutics, Inc.  230.57 %$ 230.572 millions
Inovio Pharmaceuticals, Inc.  229.03 %$ 229.027 millions
Chemocentryx, Inc.  219.75 %$ 219.750 millions
Ptc Therapeutics, Inc.  206.80 %$ 206.800 millions
Bellicum Pharmaceuticals, Inc.  203.96 %$ 203.960 millions
Cti Biopharma Corp.  201.93 %$ 201.929 millions
Orexigen Therapeutics, Inc.  199.78 %$ 199.782 millions
Enzon Pharmaceuticals, Inc.  198.20 %$ 198.195 millions
Cytomx Therapeutics, Inc.  182.87 %$ 182.870 millions
Regenxbio Inc.  176.29 %$ 176.295 millions
Exact Sciences Corp  172.11 %$ 172.108 millions
Ionis Pharmaceuticals Inc  170.74 %$ 170.736 millions
Novavax Inc  168.74 %$ 168.743 millions
Invitae Corp  156.87 %$ 156.872 millions
Biolargo, Inc.  156.45 %$ 156.446 millions
Rewalk Robotics Ltd.  145.65 %$ 145.655 millions
Viewray, Inc.  133.44 %$ 133.445 millions
Second Sight Medical Products Inc  115.62 %$ 115.622 millions
Novocure Ltd  114.16 %$ 114.164 millions
Geovax Labs, Inc.  111.77 %$ 111.774 millions
Kite Pharma, Inc.  109.64 %$ 109.635 millions
U.s. Stem Cell, Inc.  104.34 %$ 104.345 millions
Innovus Pharmaceuticals, Inc.  99.96 %$ 99.962 millions
Adamis Pharmaceuticals Corp  97.36 %$ 97.363 millions
Biocept Inc  92.95 %$ 92.946 millions
Dimension Therapeutics, Inc.  84.27 %$ 84.268 millions